HuagongsheHuagongshe Chemistry Print Report · For research reference only
Sodium triacetoxyborohydride → 2-methyl-6-phenyl-5-{4-[4-(6-trifluoromethyl-1H-benzimidazol-2-yl)-piperidin-1-ylmethyl]-phenyl}-[1,2,4]-triazolo[1,5-a]pyrimidine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Sodium triacetoxyborohydride | HCID 5049666 | — |
| Reactant | 2-Piperidine-4-yl-6-trifluoromethyl-1h-benzimidazole hydrochloride salt | HCID 68752934 | — |
| Reactant | 4-(2-Methyl-6-phenyl[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)benzaldehyde | HCID 86630681 | — |
| Product | 2-methyl-6-phenyl-5-{4-[4-(6-trifluoromethyl-1H-benzimidazol-2-yl)-piperidin-1-ylmethyl]-phenyl}-[1,2,4]-triazolo[1,5-a]pyrimidine | HCID 68751457 | 30% |
Reaction Steps
200 mg (0.64 mmol) 4-(2-methyl-6-phenyl[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)benzaldehyde and 232 mg (0.64 mmol) 2-piperidine-4-yl-6-trifluoromethyl-1H-benzimidazole hydrochloride salt were treated as described in example 2.0. Additional NaBH(OAc)3 has been added after 24 and 26 hours (two equivalents each). After five days stirring at room temperature the solvents have been evaporated and the residue was purified via chromatography. 109 mg of the desired compound were obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08957064B2 |
| Source dataset | uspto-grants-2015_02 |
| ORD ID | ord-4b919ca7771940ce955447a9a7c65036 |
| Source note | uspto-grants-2015_02 |